instem scientific limited
instem scientific limited Company Information
Company Number
03861669
Next Accounts
Sep 2025
Shareholders
instem limited
Group Structure
View All
Industry
Other information technology and computer service activities
Registered Address
diamond way stone business park, stone, staffordshire, ST15 0SD
Website
www.instem.cominstem scientific limited Estimated Valuation
Pomanda estimates the enterprise value of INSTEM SCIENTIFIC LIMITED at £583.1k based on a Turnover of £1m and 0.56x industry multiple (adjusted for size and gross margin).
instem scientific limited Estimated Valuation
Pomanda estimates the enterprise value of INSTEM SCIENTIFIC LIMITED at £0 based on an EBITDA of £-837k and a 3.84x industry multiple (adjusted for size and gross margin).
instem scientific limited Estimated Valuation
Pomanda estimates the enterprise value of INSTEM SCIENTIFIC LIMITED at £22m based on Net Assets of £9.7m and 2.26x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Instem Scientific Limited Overview
Instem Scientific Limited is a live company located in staffordshire, ST15 0SD with a Companies House number of 03861669. It operates in the other information technology service activities sector, SIC Code 62090. Founded in October 1999, it's largest shareholder is instem limited with a 100% stake. Instem Scientific Limited is a mature, small sized company, Pomanda has estimated its turnover at £1m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Instem Scientific Limited Health Check
Pomanda's financial health check has awarded Instem Scientific Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
8 Weak
Size
annual sales of £1m, make it smaller than the average company (£7.4m)
£1m - Instem Scientific Limited
£7.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -50%, show it is growing at a slower rate (8%)
-50% - Instem Scientific Limited
8% - Industry AVG
Production
with a gross margin of 25.8%, this company has a higher cost of product (51.5%)
25.8% - Instem Scientific Limited
51.5% - Industry AVG
Profitability
an operating margin of -86.5% make it less profitable than the average company (3.6%)
-86.5% - Instem Scientific Limited
3.6% - Industry AVG
Employees
with 11 employees, this is below the industry average (43)
11 - Instem Scientific Limited
43 - Industry AVG
Pay Structure
on an average salary of £102.4k, the company has a higher pay structure (£74.4k)
£102.4k - Instem Scientific Limited
£74.4k - Industry AVG
Efficiency
resulting in sales per employee of £94.3k, this is less efficient (£178.2k)
£94.3k - Instem Scientific Limited
£178.2k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (52 days)
0 days - Instem Scientific Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 31 days, this is close to average (33 days)
31 days - Instem Scientific Limited
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Instem Scientific Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (14 weeks)
4 weeks - Instem Scientific Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.3%, this is a lower level of debt than the average (64.8%)
12.3% - Instem Scientific Limited
64.8% - Industry AVG
INSTEM SCIENTIFIC LIMITED financials
Instem Scientific Limited's latest turnover from December 2023 is £1 million and the company has net assets of £9.7 million. According to their latest financial statements, Instem Scientific Limited has 11 employees and maintains cash reserves of £101 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,037,000 | 1,153,000 | 6,982,000 | 8,514,000 | 2,838,000 | 5,136,000 | 3,729,000 | 2,752,000 | 1,716,000 | 2,032,000 | 939,000 | 1,120,000 | 1,279,000 | 1,311,816 | |
| Other Income Or Grants | 0 | 0 | |||||||||||||
| Cost Of Sales | 0 | 226,772 | |||||||||||||
| Gross Profit | 1,279,000 | 1,085,044 | |||||||||||||
| Admin Expenses | 879,000 | 2,692,001 | |||||||||||||
| Operating Profit | -897,000 | -34,000 | 2,212,000 | 3,912,000 | 1,933,000 | 587,000 | 437,000 | -529,000 | 201,000 | 400,000 | -1,606,957 | ||||
| Interest Payable | 1,000 | 330,000 | 68,000 | 6,000 | 67,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15,000 | 104,544 | |
| Interest Receivable | 105,000 | 0 | 0 | 5,000 | 157,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81 | |
| Pre-Tax Profit | -932,000 | -364,000 | 2,144,000 | 3,911,000 | 2,023,000 | -95,000 | 563,000 | 447,000 | -529,000 | 293,000 | 16,000 | 201,000 | 385,000 | -1,711,420 | |
| Tax | -63,000 | 22,000 | 18,000 | -194,000 | -230,000 | -246,000 | 87,000 | 363,000 | 247,000 | 13,000 | -4,000 | -4,000 | 20,000 | 0 | |
| Profit After Tax | -995,000 | -342,000 | 2,162,000 | 3,717,000 | 1,793,000 | -341,000 | 650,000 | 810,000 | -282,000 | 306,000 | 12,000 | 197,000 | 405,000 | -1,711,420 | |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Retained Profit | -995,000 | -342,000 | 2,162,000 | 3,717,000 | 1,793,000 | -341,000 | 650,000 | 810,000 | -282,000 | 306,000 | 12,000 | 197,000 | 405,000 | -1,711,420 | |
| Employee Costs | 1,126,000 | 714,000 | 693,000 | 648,000 | 547,000 | 436,000 | 422,000 | 472,000 | 513,000 | 645,000 | 671,000 | 677,000 | 697,000 | 856,849 | |
| Number Of Employees | 11 | 13 | 14 | 14 | 12 | 10 | 10 | 10 | 11 | 13 | 15 | 15 | 15 | 14 | |
| EBITDA* | -837,000 | 19,000 | 2,261,000 | 3,992,000 | 1,993,000 | 627,000 | 490,000 | -480,000 | 210,000 | 403,000 | -1,591,748 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 104,000 | 358,000 | 645,000 | 396,000 | 698,000 | 552,000 | 801,000 | 715,000 | 368,000 | 138,000 | 27,000 | 36,000 | 6,000 | 2,263 | 17,668 |
| Intangible Assets | 156,000 | 58,000 | 0 | 0 | 0 | 23,000 | 59,000 | 95,000 | 131,000 | 157,000 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 1,982,844 |
| Debtors (Due After 1 year) | 3,000 | 258,000 | 217,000 | 87,000 | 220,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 260,000 | 416,000 | 428,000 | 309,000 | 478,000 | 575,000 | 860,000 | 810,000 | 499,000 | 295,000 | 127,000 | 136,000 | 106,000 | 102,263 | 2,000,512 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 2,000 | 0 | 127,000 | 5,000 | 71,000 | 35,000 | 456,000 | 112,000 | 70,000 | 1,015,000 | 151,000 | 164,000 | 344,000 | 247,625 | 1,011,057 |
| Group Debtors | 10,676,000 | 10,597,000 | 10,431,000 | 8,180,000 | 5,612,000 | 740,000 | 2,069,000 | 908,000 | 553,000 | 0 | 625,000 | 743,000 | 404,000 | 311,962 | 0 |
| Misc Debtors | 53,000 | 5,000 | 7,000 | 3,000 | 4,000 | 93,000 | 12,000 | 20,000 | 26,000 | 0 | 21,000 | 25,000 | 28,000 | 88,902 | 0 |
| Cash | 101,000 | 27,000 | 371,000 | 420,000 | 10,000 | 68,000 | 112,000 | 93,000 | 27,000 | 195,000 | 286,000 | 130,000 | 147,000 | 140,612 | 127,547 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 10,832,000 | 10,629,000 | 10,936,000 | 8,608,000 | 5,697,000 | 936,000 | 2,649,000 | 1,133,000 | 676,000 | 1,210,000 | 1,083,000 | 1,062,000 | 923,000 | 789,101 | 1,138,604 |
| total assets | 11,092,000 | 11,045,000 | 11,364,000 | 8,917,000 | 6,175,000 | 1,511,000 | 3,509,000 | 1,943,000 | 1,175,000 | 1,505,000 | 1,210,000 | 1,198,000 | 1,029,000 | 891,364 | 3,139,116 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 66,000 | 5,000 | 2,000 | 2,000 | 11,000 | 1,000 | 11,000 | 19,000 | 30,000 | 829,000 | 1,000 | 6,000 | 5,000 | 108,159 | 1,567,905 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 726,000 | 912,000 | 728,000 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 37,000 | 43,000 | 42,000 | 40,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,157,000 | 284,000 | 377,000 | 259,000 | 1,295,000 | 1,940,000 | 1,879,000 | 970,000 | 1,022,000 | 267,000 | 541,000 | 374,000 | 609,000 | 1,498,187 | 0 |
| total current liabilities | 1,223,000 | 326,000 | 422,000 | 303,000 | 1,346,000 | 1,941,000 | 1,890,000 | 989,000 | 1,052,000 | 1,096,000 | 1,268,000 | 1,292,000 | 1,342,000 | 1,606,346 | 1,567,905 |
| loans | 0 | 0 | 74,000 | 160,000 | 242,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 37,000 | 80,000 | 121,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,018 | 577,790 |
| provisions | 276,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36,000 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 138,000 | 0 | 37,000 | 80,000 | 121,000 | 0 | 0 | 0 | 0 | 18,000 | 0 | 0 | 0 | 3,018 | 577,790 |
| total liabilities | 1,361,000 | 326,000 | 459,000 | 383,000 | 1,467,000 | 1,941,000 | 1,890,000 | 989,000 | 1,052,000 | 1,114,000 | 1,268,000 | 1,292,000 | 1,342,000 | 1,609,364 | 2,145,695 |
| net assets | 9,731,000 | 10,719,000 | 10,905,000 | 8,534,000 | 4,708,000 | -430,000 | 1,619,000 | 954,000 | 123,000 | 391,000 | -58,000 | -94,000 | -313,000 | -718,000 | 993,421 |
| total shareholders funds | 9,731,000 | 10,719,000 | 10,905,000 | 8,534,000 | 4,708,000 | -430,000 | 1,619,000 | 954,000 | 123,000 | 391,000 | -58,000 | -94,000 | -313,000 | -718,000 | 993,421 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -897,000 | -34,000 | 2,212,000 | 3,912,000 | 1,933,000 | 587,000 | 437,000 | -529,000 | 201,000 | 400,000 | -1,606,957 | ||||
| Depreciation | 0 | 0 | 49,000 | 42,000 | 37,000 | 3,000 | 4,000 | 17,000 | 25,000 | 15,000 | 17,000 | 9,000 | 3,000 | 15,209 | 14,508 |
| Amortisation | 60,000 | 53,000 | 0 | 38,000 | 23,000 | 36,000 | 36,000 | 36,000 | 24,000 | 30,000 | 0 | 0 | 0 | 0 | 0 |
| Tax | -63,000 | 22,000 | 18,000 | -194,000 | -230,000 | -246,000 | 87,000 | 363,000 | 247,000 | 13,000 | -4,000 | -4,000 | 20,000 | 0 | |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -126,000 | 78,000 | 2,507,000 | 2,368,000 | 5,039,000 | -1,669,000 | 1,497,000 | 391,000 | -366,000 | 218,000 | -135,000 | 156,000 | 127,511 | -362,568 | 1,011,057 |
| Creditors | 61,000 | 3,000 | 0 | -9,000 | 10,000 | -10,000 | -8,000 | -11,000 | -799,000 | 828,000 | -5,000 | 1,000 | -103,159 | -1,459,746 | 1,567,905 |
| Accruals and Deferred Income | 873,000 | -93,000 | 118,000 | -1,036,000 | -645,000 | 61,000 | 909,000 | -52,000 | 755,000 | -274,000 | 167,000 | -235,000 | -889,187 | 1,498,187 | 0 |
| Deferred Taxes & Provisions | 276,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -36,000 | 36,000 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 436,000 | -127,000 | -110,000 | 385,000 | -3,911,000 | 118,000 | 399,000 | 53,000 | -184,000 | -696,857 | -1,190,739 | ||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,882,844 | 1,982,844 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -726,000 | -186,000 | 184,000 | 728,000 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | -74,000 | -86,000 | -82,000 | 242,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -37,000 | -43,000 | -42,000 | -39,000 | 161,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,018 | -574,772 | 577,790 |
| share issue | |||||||||||||||
| interest | 104,000 | -330,000 | -68,000 | -1,000 | 90,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,000 | -104,463 | |
| cash flow from financing | 74,000 | -291,000 | 13,000 | -13,000 | 3,838,000 | -1,708,000 | 15,000 | 21,000 | 14,000 | -583,000 | -162,000 | 206,000 | 709,982 | -679,236 | |
| cash and cash equivalents | |||||||||||||||
| cash | 74,000 | -344,000 | -49,000 | 410,000 | -58,000 | -44,000 | 19,000 | 66,000 | -168,000 | -91,000 | 156,000 | -17,000 | 6,388 | 13,065 | 127,547 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 74,000 | -344,000 | -49,000 | 410,000 | -58,000 | -44,000 | 19,000 | 66,000 | -168,000 | -91,000 | 156,000 | -17,000 | 6,388 | 13,065 | 127,547 |
instem scientific limited Credit Report and Business Information
Instem Scientific Limited Competitor Analysis
Perform a competitor analysis for instem scientific limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in ST15 area or any other competitors across 12 key performance metrics.
instem scientific limited Ownership
INSTEM SCIENTIFIC LIMITED group structure
Instem Scientific Limited has 1 subsidiary company.
Ultimate parent company
ALLERGO MED SARL
#0160763
2 parents
INSTEM SCIENTIFIC LIMITED
03861669
1 subsidiary
instem scientific limited directors
Instem Scientific Limited currently has 2 directors. The longest serving directors include Mr Philip Reason (Mar 2011) and Mr Jegan Thirukailayanathan (Apr 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Philip Reason | 63 years | Mar 2011 | - | Director | |
| Mr Jegan Thirukailayanathan | England | 44 years | Apr 2024 | - | Director |
P&L
December 2023turnover
1m
-10%
operating profit
-897k
+2538%
gross margin
25.8%
-2.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
9.7m
-0.09%
total assets
11.1m
0%
cash
101k
+2.74%
net assets
Total assets minus all liabilities
instem scientific limited company details
company number
03861669
Type
Private limited with Share Capital
industry
62090 - Other information technology and computer service activities
incorporation date
October 1999
age
26
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
biowisdom limited (January 2012)
redona limited (November 1999)
accountant
-
auditor
-
address
diamond way stone business park, stone, staffordshire, ST15 0SD
Bank
HSBC BANK PLC
Legal Advisor
-
instem scientific limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to instem scientific limited. Currently there are 2 open charges and 4 have been satisfied in the past.
instem scientific limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INSTEM SCIENTIFIC LIMITED. This can take several minutes, an email will notify you when this has completed.
instem scientific limited Companies House Filings - See Documents
| date | description | view/download |
|---|
